Plante Moran Financial Advisors, LLC Ironwood Pharmaceuticals Inc Transaction History

Plante Moran Financial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$14.31 - $17.65 $1,130 - $1,394	-79 Closed	0 $0
Q2 2018 Jul 26, 2018	SELL	$11.83 - $16.2 $508 - $696	-43 Reduced 35.25%	79 $2,000
Q1 2018 May 01, 2018	BUY	$11.13 - $13.63 $478 - $586	43 Added 54.43%	122 $2,000
Q3 2017 Nov 08, 2017	BUY	$12.07 - $14.87 $953 - $1,174	79	79 $1,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.